PankoMab-GEX (also known as gatipotuzumab) is a humanized IgG1 targeting tumor-associated mucin-1 (TA-MUC1), which is a novel carbohydrate-induced conformational epitope overexpressed only on the surface of tumor cells, and can efficiently recognize tumor cells [74]. The gene discussed is MUC1; the disease is neoplasm.